These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 37274917)

  • 41. Trajectories of vital signs in patients with COVID-19.
    Pimentel MAF; Redfern OC; Hatch R; Young JD; Tarassenko L; Watkinson PJ
    Resuscitation; 2020 Nov; 156():99-106. PubMed ID: 32918984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
    Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
    Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of hematological parameters in COVID-19 patients in the emergency room.
    Usul E; Şan İ; Bekgöz B; Şahin A
    Biomark Med; 2020 Sep; 14(13):1207-1215. PubMed ID: 32692248
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19.
    Chan AS; Rout A
    J Clin Med Res; 2020 Jul; 12(7):448-453. PubMed ID: 32655740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
    Fox SE; Akmatbekov A; Harbert JL; Li G; Quincy Brown J; Vander Heide RS
    Lancet Respir Med; 2020 Jul; 8(7):681-686. PubMed ID: 32473124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
    Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of asymptomatic infections with COVID-19.
    Gao Z; Xu Y; Sun C; Wang X; Guo Y; Qiu S; Ma K
    J Microbiol Immunol Infect; 2021 Feb; 54(1):12-16. PubMed ID: 32425996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of sex and gender on immunotherapy outcomes.
    Klein SL; Morgan R
    Biol Sex Differ; 2020 May; 11(1):24. PubMed ID: 32366281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine release syndrome in severe COVID-19.
    Moore JB; June CH
    Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
    [No Abstract]   [Full Text] [Related]  

  • 52. Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.
    Di Gennaro F; Pizzol D; Marotta C; Antunes M; Racalbuto V; Veronese N; Smith L
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32295188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    Liu Y; Du X; Chen J; Jin Y; Peng L; Wang HHX; Luo M; Chen L; Zhao Y
    J Infect; 2020 Jul; 81(1):e6-e12. PubMed ID: 32283162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-reactive protein levels in the early stage of COVID-19.
    Wang L
    Med Mal Infect; 2020 Jun; 50(4):332-334. PubMed ID: 32243911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
    Lagunas-Rangel FA
    J Med Virol; 2020 Oct; 92(10):1733-1734. PubMed ID: 32242950
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China.
    Mo P; Xing Y; Xiao Y; Deng L; Zhao Q; Wang H; Xiong Y; Cheng Z; Gao S; Liang K; Luo M; Chen T; Song S; Ma Z; Chen X; Zheng R; Cao Q; Wang F; Zhang Y
    Clin Infect Dis; 2021 Dec; 73(11):e4208-e4213. PubMed ID: 32173725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
    Ruan Q; Yang K; Wang W; Jiang L; Song J
    Intensive Care Med; 2020 May; 46(5):846-848. PubMed ID: 32125452
    [No Abstract]   [Full Text] [Related]  

  • 58. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease.
    Lin C; Ding Y; Xie B; Sun Z; Li X; Chen Z; Niu M
    Clin Imaging; 2020 Jul; 63():7-9. PubMed ID: 32120312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
    Xu Z; Shi L; Wang Y; Zhang J; Huang L; Zhang C; Liu S; Zhao P; Liu H; Zhu L; Tai Y; Bai C; Gao T; Song J; Xia P; Dong J; Zhao J; Wang FS
    Lancet Respir Med; 2020 Apr; 8(4):420-422. PubMed ID: 32085846
    [No Abstract]   [Full Text] [Related]  

  • 60. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.